Cytomegalovirus (CMV) damage of the lungs associated with pulmonary tumours: is it a fortuitousness or a rule?

V. I. Shakhgildian, O. A. Tishkevich, Y. G. Parkhomenko (Moscow, Russia)

Source: Annual Congress 2003 - Lung cancer: clinical presentation and prognostic factors
Session: Lung cancer: clinical presentation and prognostic factors
Session type: Thematic Poster Session
Number: 1648
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. I. Shakhgildian, O. A. Tishkevich, Y. G. Parkhomenko (Moscow, Russia). Cytomegalovirus (CMV) damage of the lungs associated with pulmonary tumours: is it a fortuitousness or a rule?. Eur Respir J 2003; 22: Suppl. 45, 1648

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Epstein-Barr virus specific antibodies in patients with idiopathic pulmonary fibrosis and presence of EBV in respiratory tract: reactivation of infection?
Source: Eur Respir J 2005; 26: Suppl. 49, 333s
Year: 2005

Cytomegalovirus damage of the lungs among patients with HIV-infection
Source: Eur Respir J 2002; 20: Suppl. 38, 195s
Year: 2002

EBV and CMV as possible pathogens in patients presenting with interstitial lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 154s
Year: 2006

Cavitary lung masses in SLE patients: an unusual manifestation of CMV infection
Source: Eur Respir J 2004; 24: 182-184
Year: 2004



Cytomegalovirus infection in patients with lung tuberculosis
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018

Pulmonary lymphoid hyperplasia (PLH) / lymphoid interstitial pneumonitis (LIP) complex in HIV-1 infected Brazilian children: associations and prognosis
Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring
Year: 2008


Cytomegalovirus: an unrecognised potential contributor to cystic fibrosis disease progression?
Source: Eur Respir J, 53 (4) 1801727; 10.1183/13993003.01727-2018
Year: 2019



Effective prevention of human cytomegalovirus (HCMV) disease in lung transplant recipients (LTR) by pre-emptive therapy based on HCMV monitoring in blood and lung
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019

Cytomegalovirus infection in lung transplant patients: the role of prophylaxis and recipient-donor serotype matching
Source: Eur Respir J 2005; 26: Suppl. 49, 636s
Year: 2005

The frequency of cytomegalovirus infection detecting of patients with lung diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 153s
Year: 2006

Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006


Immunity status of community acquired pneumonia (CAP) young patients according concomitant cytomegalovirus persistence (CMVP)
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019


Non-infectious pulmonary complications in immunocompromised (IC) patients. Associated pulmonary and systemic inflammatory response
Source: Eur Respir J 2004; 24: Suppl. 48, 241s
Year: 2004

Pulmonary tuberculosis (TB) as a complication of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009


Human lung transplantation: cytomegaloviral and rhinoviral co-infection is a distinct risk for acute rejection
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009

Pulmonary diseases in primary immunodeficiency syndromes
Source: Respipedia Article
Year: 2017

Detection of herpes simplex virus type-1 (HSV-1) in lung tissue and bronchoalveolar lavage fluid (BALF) of patients with fibrotic idiopathic interstitial pneumonias (f-IIPs)
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009


The role of cytomegalovirus infection in the course of the lung diseases in children
Source: Eur Respir J 2005; 26: Suppl. 49, 643s
Year: 2005

Herpes-simplex virus (HSV) in pulmonary tuberculosis (TB) with delayed response to treatment in patients from radio-nuclide contaminated areas (RNCA)
Source: Eur Respir J 2002; 20: Suppl. 38, 558s
Year: 2002

Risk of disease and latent infection among contacts of pulmonary and pleural tuberculosis in santarem (Portugal)
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009